 Pericardial effusion intravenous recombinant tissue-type plasminogen activator acute myocardial infarction effect thrombolytic therapy frequency time course sequelae pericardial effusion myocardial infarction unknown prospective serial echocardiographic study patients myocardial infarction recombinant tissue-type plasminogen activator rt-PA issue study population patients first Thrombolysis Angioplasty Myocardial Infarction trial Duke University Medical Center Enrollment serial echocardiography protocol equipment support staff availability Complete echocardiographic studies minutes initiation thrombolytic therapy day days Patients serial echocardiography demographic clinical characteristics Pericardial effusion present patients day day day day day pericardial effusions moderate size large remainder small patients echocardiographic hemodynamic signs cardiac tamponade prevalence time course pericardial effusion patients acute myocardial infarction rt-PA study similar observations studies patients thrombolytic therapy Adverse sequelae pericardial effusion thrombolytic therapy rare